The UK Glucose Insulin in Stroke Trial (GIST-UK) [6] and The Stroke Hyperglycaemia Insulin Network Effort (SHINE) [7] randomized clinical trials failed to demonstrate the benefit of intensive glucose control in patients with stroke. The gene discussed is INS; the disease is Stroke.